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Draft Genome Sequence of the Biofilm-Forming Stenotrophomonas
maltophilia Strain 53
Sirwan Akbar, Simon P. Rout, Paul N. Humphreys
Department of Biological Sciences, School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom
A clinical strain of Stenotrophomonas maltophilia (designated strain 53) was obtained, and a whole-genome sequence was gener-
ated. The subsequent draft whole-genome sequence demonstrated the presence of a number of genes encoding for proteins in-
volved in resistance to a number of antimicrobial therapies.
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S
tenotrophomonas maltophilia is an aerobic, Gram-negative,
and nonfermentative microorganism, originally described as
Bacterium booker in 1943 before being placed in the novel genus
Stenotrophomonas in 1993 (1). Strains of Stenotrophomonas malto-
philia have been found almost ubiquitously within natural envi-
ronments, including freshwater sources, and within both the soil
and plant microbiomes (2–4). This species has received attention
with regard to its bioremediation properties, where the degrada-
tion of a number of contaminants has been described (5, 6).
Within a clinical setting, members of this species also represent
a risk of nosocomial infection, where it is an opportunistic
pathogen to immunosuppressed or debilitated individuals (7,
8). Mechanisms such as decreased permeability, -lactamases,
aminoglycoside-modifying enzymes, and the presence of efflux
pumps within the outer membrane aid this pathogenicity (9).
This resistance appears to be mediated not only by intrinsic
resistance mechanisms but also through its ability to acquire
resistance via uptake and integration of genetic information
into the host chromosome (10).
A hospital isolate of Stenotrophomonas maltophilia was ob-
tained and subcultured into tryptone soya broth. Following incu-
bation for 24 h at 37°C, total genomic DNA was isolated using a
commercial kit (Ultracleanmicrobial isolation kit;Mo-Bio,USA).
A draft whole-genome sequence was obtained using a whole-
genome shotgun sequence strategy. Paired-end 125-cycle se-
quence reads were generated using Illumina HiSeq 2500 technol-
ogy (BaseClear, Netherlands). FASTQ sequence files were
generated using the Illumina CASAVA pipeline version 1.8.3, and
the CLC Genomics Workbench version 7.0 was used for assem-
bly. The contigs were linked and placed into scaffolds or super-
contigs. The orientation, order, and distance between the contigs
were estimated using the insert size between the paired-end
and/or mate-pair reads using the SSPACE Premium scaffolder
version 2.3 (11). Whole-genome sequencing generated 128 con-
tigs with a draft genome 4,637,878 bp in length and a GC con-
tent of 66.3%. The draft genome contained a total of 4,082 coding
sequences (CDS), where 77 pseudogenes, 3 genes coding for rRNA
(5S, 16S, 23S), 64 genes coding for tRNAs, and 1 noncoding RNA
were present. RAST (12) annotation showed that 31 genes were
present encoding multidrug-resistance efflux pumps, 21 were in-
volved in cobalt-zinc-cadmium resistance and 10 genes were in-
volved in the production of-lactamases. Also present were genes
involved in resistance to arsenic and fluoroquinolones, as well as
tripartite efflux pumps and a single gene encoding an aminogly-
coside adenylyltransferase. In addition, genes were present that
were responsible for encoding proteins involved in the synthesis of
biofilms, which are likely to enhance its pathogenicity (13). Over-
all, the strain demonstrates the potential for resistance to a wide
range of antimicrobial strategies within the clinical setting.
Nucleotide sequence accession number. This whole-genome
shotgun project has been deposited at DDBJ/EMBL/GenBank un-
der the accession number JRJA00000000.
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